Crocs CEO trust sells 30,000 shares of stock

Crocs, Inc. reported that a trust associated with Chief Executive Officer Andrew Rees sold a total of 30,000 shares of common stock on August 7 and 10, 2026 in open-market transactions.

Rhea-AI Filing Summary

Crocs, Inc. reported that a trust associated with Chief Executive Officer Andrew Rees sold a total of 30,000 shares of common stock on August 7 and 10, 2026 in open-market transactions. The weighted-average sale prices came from ranges between $136.78 and $140.05 per share. A separate entry shows Rees holding 570,179 shares of common stock directly as of August 7, 2026.

Insider Trade Summary

Net Seller: 30,000 shares

Net Sell 7 txns

Insider Rees Andrew

Role Chief Executive Officer

Sold 30,000 shs ($4.15M)

Type	Security	Shares	Price	Value
Sale	Common Stock F5, F2	9,576	$138.3812	$1.33M
Sale	Common Stock F6, F2	8,696	$139.3938	$1.21M
Sale	Common Stock F7, F2	800	$140.0163	$112K
Sale	Common Stock F1, F2	5,796	$137.4143	$796K
Sale	Common Stock F3, F2	4,204	$137.9603	$580K
Sale	Common Stock F4, F2	928	$139.0372	$129K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 713,293 shares (Indirect, By Trust); Common Stock — 570,179 shares (Direct)

Footnotes (7)

1. F1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.78 - $137.77, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.
2. F2. The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust.
3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.79 to $138.10, inclusive.
4. F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.01 to $139.14, inclusive.
5. F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.00 to $138.98, inclusive.
6. F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.00 to $139.96, inclusive.
7. F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.00 to $140.05, inclusive.

Key Figures

Total shares sold: 30000 shares Sale transactions count: 6 transactions Lowest price range: $136.78 +3 more

6 metrics

Total shares sold 30000 shares Common stock sold indirectly by trust over August 7 and 10, 2026

Sale transactions count 6 transactions Six non-derivative sale entries of common stock reported

Lowest price range $136.78 Lower end of weighted-average price range disclosed in footnote F1

Highest price range $140.05 Upper end of weighted-average price range disclosed in footnote F7

Direct holdings after 570179 shares Directly held common stock reported as of August 7, 2026

Largest single sale block 9576 shares Indirect sale on August 10, 2026 at $138.3812 per share weighted average

Key Terms

weighted average price, beneficially owned, indirect ownership, voting and investment power

4 terms

weighted average price financial

"The price reported in Column 4 is a <b>weighted average price</b>."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficially owned financial

"shares <b>beneficially owned</b> by the trust"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

indirect ownership financial

"Ownership type reported as "I" indicating <b>indirect ownership</b> by trust"

voting and investment power financial

"trustee ... exercises <b>voting and investment power</b> for the shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Crocs (CROX) report for Andrew Rees?

Crocs reported that a trust associated with CEO Andrew Rees sold a total of 30,000 shares of common stock on August 7 and 10, 2026 in open-market transactions at weighted-average prices within specified ranges.

How many Crocs (CROX) shares did the CEO-linked trust sell and at what prices?

The trust associated with the CEO sold 30,000 shares of Crocs common stock. Weighted-average prices for the trades came from ranges between $136.78 and $140.05 per share, according to the transaction footnotes describing multiple executions within each range.

On which dates did the Crocs (CROX) CEO-related sales occur?

The sales linked to the Crocs CEO’s trust occurred on August 7, 2026 and August 10, 2026. Multiple open-market transactions were executed on each date, each reported with a weighted-average price and detailed price ranges in the accompanying footnotes.

What type of ownership was reported for the Crocs (CROX) shares sold by the CEO-related entity?

The sold shares were reported as indirectly owned, described as held "By Trust." A footnote states Andrew Rees is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power over the trust’s beneficially owned shares.

How many Crocs (CROX) shares does Andrew Rees hold directly after these transactions?

A separate holding line shows Andrew Rees directly owning 570,179 shares of Crocs common stock as of August 7, 2026. This direct holding figure is reported separately from the shares sold by the trust, which are categorized as indirect ownership.

Were the Crocs (CROX) insider sales reported as single trades or multiple executions?

Each reported sale used a weighted average price, and footnotes explain the shares were sold in multiple transactions within specified price ranges on each date. Detailed breakdowns by individual execution price are available on request from the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 11:38 AM Accepted by SEC EDGAR 08/11/2026 - 11:37 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rees Andrew

(Last) (First) (Middle)

C/O CROCS, INC.

500 ELDORADO BLVD #5

(Street)

BROOMFIELD COLORADO 80021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crocs, Inc. [ CROX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2026		S		5,796	D	$137.4143(1)	737,497	I	By Trust(2)
Common Stock	08/07/2026		S		4,204	D	$137.9603(3)	733,293	I	By Trust(2)
Common Stock	08/07/2026		S		928	D	$139.0372(4)	732,365	I	By Trust(2)
Common Stock	08/10/2026		S		9,576	D	$138.3812(5)	722,789	I	By Trust(2)
Common Stock	08/10/2026		S		8,696	D	$139.3938(6)	714,093	I	By Trust(2)
Common Stock	08/10/2026		S		800	D	$140.0163(7)	713,293	I	By Trust(2)
Common Stock								570,179	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.78 - $137.77, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.

2. The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.79 to $138.10, inclusive.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.01 to $139.14, inclusive.

5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.00 to $138.98, inclusive.

6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.00 to $139.96, inclusive.

7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.00 to $140.05, inclusive.

Remarks:

	/s/Sara Hoverstock, Attorney-in-Fact	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)